Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Thrombosis and Haemostasis

• Publication date

  2001-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1615646PMID 11341498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cellular origin and procoagulant properties of microparticles in meningococcal sepsis.

  2000cited by this paper
• High levels of coagulation factor XI as a risk factor for venous thrombosis.

  2000cited by this paper
• Measurement of Tissue Factor Activity in Whole Blood

  2000cited by this paper
• Blood-borne tissue factor: another view of thrombosis.

  1999cited by this paper
• In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.

  1999cited by this paper
• Effect of Cilostazol on Soluble Adhesion Molecules and Platelet-derived Microparticles in Patients with Diabetes

  1998cited by this paper
• Molecular Cloning of Platelet Factor XI, an Alternative Splicing Product of the Plasma Factor XI Gene*

  1998cited by this paper
• Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells.

  1998cited by this paper
• Cytokine-dependent abortion in CBA x DBA/2 mice is mediated by the procoagulant fgl2 prothrombinase [correction of prothombinase].

  1998cited by this paper
• Tissue factor expression by monocytes: regulation and pathophysiological roles.

  1998cited by this paper
• Tissue-specific expression of functional platelet factor XI is independent of plasma factor XI expression.

  1998cited by this paper
• Cutting Edge: Cytokine-Dependent Abortion in CBA × DBA/2 Mice Is Mediated by the Procoagulant fgl2 Prothombinase

  1998cited by this paper
• Platelet microparticles and calcium homeostasis in acute coronary ischemias

  1997cited by this paper
• Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.

  1997cited by this paper
• Annexin V inhibition of factor IXa-catalyzed factor X activation on human platelets and on negatively-charged phospholipid vesicles.

  1996cited by this paper
• Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura

  1996cited by this paper
• Platelet-derived microparticles associate with fibrin during thrombosis.

  1996cited by this paper
• Role of tissue factor and factor VIIa in the coagulant and inflammatory response to LD100 Escherichia coli in the baboon.

  1996cited by this paper
• Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia.

  1996cited by this paper
• Platelet‐derived microvesicles and activated platelets express factor Xa activity

  1995cited by this paper
• Tissue factor expression in endothelial cells in health and disease

  1995cited by this paper
• Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis.

  1995cited by this paper
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

  1994cited by this paper
• Amyloid β-Protein Precursor-Rich Platelet Microparticles in Thrombotic Disease

  1994cited by this paper
• Prolonged circulation of activated platelets following plasmapheresis

  1994cited by this paper
• Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide.

  1994cited by this paper
• Surface Independent Factor XI Activation by Thrombin in the Presence of High Molecular Weight Kininogen

  1994cited by this paper
• Tissue factor in plasma of patients with disseminated intravascular coagulation

  1994cited by this paper
• A Chromogenic Test to Determine the Procoagulant Phospholipids in Platelet-rich Plasma and Whole Blood

  1994cited by this paper
• Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias.

  1993cited by this paper
• Significance of platelet-derived microparticles in uremia.

  1993cited by this paper
• The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. In vivo use of a monoclonal anti-factor XII antibody to block contact activation in baboons.

  1993cited by this paper
• Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates.

  1993cited by this paper
• The activation of factor X and prothrombin by recombinant factor VIIa in vivo is mediated by tissue factor.

  1993cited by this paper
• Factor XII clotting activity and antigen levels in patients with thromboembolic disease

  1992cited by this paper
• Clinical significance of platelet microparticles in autoimmune thrombocytopenias.

  1992cited by this paper
• A Novel Sensitive Assay for Functional Factor XII Based on the Generation of Kallikrein-C1-lnhibitor Complexes in Factor Xll-Deficient Plasma by Glass-Bound Factor XII

  1992cited by this paper
• Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.

  1992cited by this paper
• Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody.

  1991cited by this paper
• No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate

  1991cited by this paper
• Factor XI activation in a revised model of blood coagulation

  1991cited by this paper
• Thromboembolism and Bleeding Tendency in Congenital Factor XII DeficienCy - A Study on 74 Subjects from 14 Swiss Families

  1991cited by this paper
• Platelet-derived microparticles express high affinity receptors for factor VIII.

  1991influential reference
• Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.

  1991cited by this paper
• Factor IX is activated in vivo by the tissue factor mechanism.

  1990influential reference
• The Effect of Trace Amounts of Tissue Factor on Thrombin Generation in Platelet Rich Plasma, its Inhibition by Heparin

  1989cited by this paper
• DETECTION OF FACTOR X ACTIVATION IN HUMANS

  1989cited by this paper
• Platelet receptor-mediated factor X activation by factor IXa. High-affinity factor IXa receptors induced by factor VIII are deficient on platelets in Scott syndrome.

  1989cited by this paper
• The saturable high affinity association of factor X to ADP-stimulated monocytes defines a novel function of the Mac-1 receptor.

  1988cited by this paper
• Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity.

  1988cited by this paper
• Single bilayer vesicles prepared without sonication. Physico-chemical properties.

  1976cited by this paper

• Alteration of Fatty Acid Composition of Phospholipids in EA.hy926 Endothelial Cells Is Reflected in Microvesicles during TNF-α Stimulation.

  2026cites this paper
• Biomarkers of Coagulation Disorders-Where to from Here?

  2026cites this paper
• Tissue‐Specific Extracellular Vesicles Enriched From Circulation: Exploring the Liquid Biopsy Perspective

  2026cites this paper
• The emerging roles of platelet-derived extracellular vesicles in disease

  2025cites this paper
• Platelet-derived exosomal LINC00183 facilitate colorectal cancer malignant progression driven by histone lactylation through stabilizing ENO1

  2025cites this paper
• Direct Oral Anticoagulants Are Comparable to Low Molecular Weight Heparin at Sustaining the Circulating Extracellular Vesicle and Inflammatory Profiles of Cancer Associated Thrombosis Patients: An Observational Pilot Study

  2025cites this paper
• Platelet-derived microparticles increase the interaction of colorectal cancer cells with the endothelium to promote metastatic events

  2025cites this paper
• An update on extracellular vesicles in hematologic disorders: molecular mediators, clinical biomarkers, and emerging therapeutics

  2025cites this paper
• Severe Allergy as a Chronic Inflammatory Condition From a Systems Biology Perspective

  2024cites this paper
• Platelet-derived microvesicles isolated from type-2 diabetes mellitus patients harbour an altered miRNA signature and drive MDA-MB-231 triple-negative breast cancer cell invasion

  2024cites this paper
• Differential effects of physiological agonists on the proteome of platelet‐derived extracellular vesicles

  2024influential citation
• Comparative analysis of Lox-1 and CD36 expression in human platelets and on circulating microparticles during ARDS-induced coagulopathy.

  2024cites this paper
• Membrane-Dependent Reactions of Blood Coagulation: Classical View and State-of-the-Art Concepts

  2024cites this paper
• Impact of Early Microparticle Release during Isolated Severe Traumatic Brain Injury: Correlation with Coagulopathy and Mortality.

  2024cites this paper
• Extracellular Vesicles in Lung Cancer: Implementation in Diagnosis and Therapeutic Perspectives

  2024cites this paper
• Update on Tissue Factor Detection in Blood in 2024: A Narrative Review

  2024cites this paper
• Research into New Molecular Mechanisms in Thrombotic Diseases Paves the Way for Innovative Therapeutic Approaches

  2024cites this paper
• Quantitative and structural changes of blood platelet cytoskeleton proteins in multiple sclerosis (MS).

  2024cites this paper
• Exercise Induced Changes in the Appearance of Circulating Microvesicles

  2024cites this paper
• Extracellular vesicles in disorders of hemostasis following traumatic brain injury

  2024cites this paper
• A novel rat model of cerebral small vessel disease based on vascular risk factors of hypertension, aging, and cerebral hypoperfusion

  2024cites this paper
• Extracellular Vesicles in Thalassemia: Mechanisms, Implications, and Therapeutic Potential

  2024cites this paper
• The evolving knowledge on primary hemostasis in patients with cirrhosis: A comprehensive review

  2023cites this paper
• Hypercoagulability in Sickle Cell Disease: A Thrombo-Inflammatory Mechanism

  2023cites this paper
• Adhesive properties of plasma-circulating and platelet-derived microvesicles from healthy individuals.

  2023cites this paper
• Megakaryocyte-Derived IL-8 Acts as a Paracrine Factor for Prostate Cancer Aggressiveness through CXCR2 Activation and Antagonistic AR Downregulation

  2023cites this paper
• Elevated Levels of Procoagulant Microvesicles and Tissue-Factor Bearing Microvesicles in Malaria Patients

  2023cites this paper
• Platelet-Derived Extracellular Vesicles as Lipid Carriers in Severe Allergic Inflammation

  2023cites this paper
• Shedding Light on the Cell Biology of Platelet-Derived Extracellular Vesicles and Their Biomedical Applications

  2023cites this paper
• Phosphatidylthreonine is a procoagulant lipid detected in human blood and elevated in coronary artery disease

  2023cites this paper
• Mitochondria transfer by platelet-derived microparticles regulates breast cancer bioenergetic states and malignant features.

  2023cites this paper
• The value of platelet-rich plasma-derived extracellular vesicles in modern medicine

  2023cites this paper
• Platelet‐derived microvesicles induce intracellular calcium mobilization in human platelets

  2023cites this paper
• Platelet-derived microparticles provoke chronic lymphocytic leukemia malignancy through metabolic reprogramming

  2023cites this paper
• Microparticle Phosphatidylserine Mediates Coagulation: Involvement in Tumor Progression and Metastasis

  2023cites this paper
• Platelet-Derived Extracellular Vesicles in Arterial Thrombosis.

  2023cites this paper
• The Vascular Endothelium and Coagulation: Homeostasis, Disease, and Treatment, with a Focus on the Von Willebrand Factor and Factors VIII and V

  2022influential citation
• Extracellular vesicles in atherothrombosis: From biomarkers and precision medicine to therapeutic targets

  2022cites this paper
• Platelet extracellular vesicles and the secretory interactome join forces in health and disease

  2022cites this paper
• Pathophysiology of Coagulation and Emerging Roles for Extracellular Vesicles in Coagulation Cascades and Disorders

  2022influential citation
• Rosmarinic Acid Inhibits Platelet Aggregation and Neointimal Hyperplasia In Vivo and Vascular Smooth Muscle Cell Dedifferentiation, Proliferation, and Migration In Vitro via Activation of the Keap1-Nrf2-ARE Antioxidant System.

  2022cites this paper
• Platelets at the Crossroads of Pro-Inflammatory and Resolution Pathways during Inflammation

  2022cites this paper
• The pathobiology of platelet and megakaryocyte extracellular vesicles: A (c)lot has changed

  2022cites this paper
• Platelet-Released Factors: Their Role in Viral Disease and Applications for Extracellular Vesicle (EV) Therapy

  2022cites this paper
• Angiogenic content of microparticles in patients with diabetes and coronary artery disease predicts networks of endothelial dysfunction

  2022cites this paper
• Red Blood Cell Microparticles Limit Hematoma Growth in Intracerebral Hemorrhage

  2022cites this paper
• Extracellular vesicles and lipoproteins – Smart messengers of blood cells in the circulation

  2022cites this paper
• Blood Cell-Derived Microvesicles in Hematological Diseases and beyond

  2022cites this paper
• Red Cell Microparticles Suppress Hematoma Growth Following Intracerebral Hemorrhage in Chronic Nicotine-Exposed Rats

  2022cites this paper
• Platelet Extracellular Vesicles Are Taken up by Canine T Lymphocytes but Do Not Play a Role in Their Proliferation, Differentiation and Cytokine Production In Vitro

  2022cites this paper
• Methods to evaluate vascular function: a crucial approach towards predictive, preventive, and personalised medicine

  2022cites this paper
• Circulating Extracellular Vesicles Are Strongly Associated With Cardiovascular Risk Markers

  2022cites this paper
• The Effect of Extracellular Vesicles on Thrombosis

  2022cites this paper
• Procoagulant Microvesicles in COVID-19 Patients: Possible Modulators of Inflammation and Prothrombotic Tendency

  2022cites this paper
• The Pathophysiological Role of Platelet-Derived Extracellular Vesicles

  2022cites this paper
• Platelet-released extracellular vesicles: the effects of thrombin activation

  2022cites this paper
• Platelets and (Lymph)angiogenesis.

  2022cites this paper
• Plasma levels of platelet‐derived microvesicles are associated with risk of future venous thromboembolism

  2022cites this paper
• In-line leukoreduction filters: A new source of microparticle for human and animal study.

  2022cites this paper
• Insights Into Platelet-Derived MicroRNAs in Cardiovascular and Oncologic Diseases: Potential Predictor and Therapeutic Target

  2022cites this paper
• Human platelet lysate‐derived extracellular vesicles enhance angiogenesis through miR‐126

  2022cites this paper
• Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis

  2022cites this paper
• Current Perspectives on Adult Mesenchymal Stromal Cell-Derived Extracellular Vesicles: Biological Features and Clinical Indications

  2022cites this paper
• Autologous Protein Solution processing alters lymphoid and myeloid cell populations and modulates gene expression dependent on cell type

  2022cites this paper
• Extracellular Vesicles in Blood: Sources, Effects, and Applications

  2021cites this paper
• Extracellular Vesicles: A Double-Edged Sword in Sepsis

  2021cites this paper
• The role of the calibrated automated thrombogram in neonates: describing mechanisms of neonatal haemostasis and evaluating haemostatic drugs

  2021cites this paper
• Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer

  2021cites this paper
• Horizontal MicroRNA Transfer by Platelets – Evidence and Implications

  2021cites this paper
• COVID-19 Infection and Circulating Microparticles—Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease

  2021cites this paper
• Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence

  2021influential citation
• Platelets and extracellular vesicles and their cross-talk with cancer.

  2021cites this paper
• Coagulation disorders in Chagas disease: A pathophysiological systematic review and meta-analysis.

  2021cites this paper
• Biomarkers involved in evaluation of platelets function in South-Eastern Romanian patients with hematological malignancies subtypes

  2021cites this paper
• Microparticles: a link to increased thrombin generation

  2021cites this paper
• New Insights Into Platelet-enriched miRNAs: Production, Functions, Roles in Tumors, and Potential Targets for Tumor Diagnosis and Treatment

  2021cites this paper
• Responses of platelet CD markers and indices to resistance exercise with and without blood flow restriction in patients with type 2 diabetes

  2021cites this paper
• Diets and Cellular-Derived Microparticles: Weighing a Plausible Link With Cerebral Small Vessel Disease

  2021cites this paper
• The Dynamic of Extracellular Vesicles in Patients With Subacute Stroke: Results of the “Biomarkers and Perfusion—Training-Induced Changes After Stroke” (BAPTISe) Study

  2021cites this paper
• Extracellular vesicles in Shiga toxin-mediated disease

  2021cites this paper
• [The decrease in procoagulant activity of blood during combined therapy with antidepressants and antipsychotics in patients with endogenous mental disorders].

  2021cites this paper
• Characterization and Therapeutic Use of Extracellular Vesicles Derived from Platelets

  2021cites this paper
• Labeling fibrin fibers with microparticle sized beads alter single fibrin fiber lysis, external clot lysis, and produce large fibrin aggregates upon lysis

  2021cites this paper
• Phosphatidylserine Exposing Extracellular Vesicles in Pre-eclamptic Patients

  2021cites this paper
• Rosuvastatin treatment decreases plasma procoagulant phospholipid activity after a VTE: A randomized controlled trial

  2021cites this paper
• Production of erythrocyte microparticles in a sub-hemolytic environment

  2021cites this paper
• Exosomes, microvesicles, and their friends in solid tumors

  2020cites this paper
• MICROPARTICLES IN HEMOPHILIA – FRIEND OR FOE? – TO IMPROVE HEMOSTASIS OR TO INDUCE ATHEROTHROMBOSIS?

  2020cites this paper
• Rac1 regulates platelet microparticles formation and rheumatoid arthritis deterioration

  2020cites this paper
• Novel Biomarkers for Evaluation of Endothelial Dysfunction

  2020cites this paper
• Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients.

  2020cites this paper
• Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists

  2020cites this paper
• Elevated levels of procoagulant microvesicles in patients with dengue fever

  2020cites this paper
• Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran

  2020influential citation
• Mode of induction of platelet-derived extracellular vesicles is a critical determinant of their phenotype and function

  2020cites this paper
• Oxidative Stress Product, 4-Hydroxy-2-Nonenal, Induces the Release of Tissue Factor-Positive Microvesicles From Perivascular Cells Into Circulation

  2020cites this paper
• MicroRNAs in Platelets: Should I Stay or Should I Go?

  2020cites this paper
• Impact of Epicatechin on the Procoagulant Activities of Microparticles

  2020cites this paper
• Platelet Extracellular Vesicles: Beyond the Blood.

  2020cites this paper
• A review of the role of extracellular vesicles in neonatal physiology and pathology

  2020cites this paper